Letizia Foroni
Papers
1
Total Citations
15
H-Index
1
About
Letizia Foroni is a leading molecular biologist whose work has fundamentally advanced the monitoring and treatment of hematological malignancies, particularly chronic myeloid leukemia (CML). Her primary research focuses on the molecular genetics of leukemia and the development of highly sensitive diagnostic tools for disease surveillance. Foroni’s most significant contribution is her pioneering work on the standardization and automation of RT-qPCR for BCR-ABL1 monitoring, a critical technique for managing patients with CML. Her highly cited 2012 study on "Fast-mode duplex qPCR" introduced a novel, harmonized approach that dramatically improved the speed, accuracy, and reproducibility of molecular testing, directly enabling more precise treatment decisions. This innovation has been instrumental in moving CML management toward treatment-free remission. With over 15 citations on this key paper alone, her work has had a profound impact on clinical practice, setting a new global standard for molecular monitoring. Foroni’s dedication to bridging cutting-edge research with routine clinical application has made her a pivotal figure in the fight against leukemia.
Research Focus
Key Achievements
Top Papers
- 1